NVS: NOVARTIS A G Real-Time Headlines

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 9 hrs, 12 mins

Symbol	Value	Change	Percentage Change
DJIA	10,226.94	203.52	2.03%
NASDAQ	2,154.06	41.62	1.97%
S&P 500	1,093.08	23.78	2.22%

Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Learn More

Get the FREE DailyFinance iPhone application

NOVARTIS A G

NVS

Stock price

53.58 0.78 1.48%

as of 04:02 PM EST on 11/09/2009 in USD (NYSE Delay: 15 mins.)
Extended Hours

53.53 -0.05 -0.09%

as of 04:20 PM EST on 11/09/09

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: NVS

NOVARTIS A G Real-Time Headlines

Customize
Monday, November 9, 2009

Big Pharma and Biotech - Industry Outlook

11/9/09 | Zacks Investment Research

Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million

11/9/09 View all Related Articles > | StockWatch

A Big Upgrade for Gilead Sciences

11/9/09 | The Motley Fool

The first movers in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer ..

11/9/09 | PR-inside - Austria

Supreme Court to review business method patents, WSJ reports

11/9/09 | Theflyonthewall.com

Practicing Balance with P&G: China Watch

11/9/09 | TheStreet.com

Sunday, November 8, 2009

China Is Growth Market for Novartis

11/8/09 View all Related Articles > | Seeking Alpha

Saturday, November 7, 2009

Novartis Receives Regulatory Approval In Germany For Celtura®, A Cell Culture-based Influenza A(H1N1) Pandemic Vaccine

11/7/09 View all Related Articles > | PharmaInfo.net - Canada

Thursday, November 5, 2009

South Korean FDA raids Roche office over Tamiflu investigation, FT reports

11/5/09 | Theflyonthewall.com

Distribution of H1N1

11/5/09 | CNBC Video

Lower Q3 Loss for Human Genome - Analyst Blog

11/5/09 | Zacks Investment Research

Novartis receives regulatory approval in Germany for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine

11/5/09 | PharmiWeb.com - UK

Novartis receives regulatory approval in Germany for Celtura, a cell culture-based Influenza A(H1N1) pandemic vaccine

11/5/09 View all Related Articles > | PharmaLive

Germany OK's Novartis swine flu vaccine from cells

11/5/09 View all Related Articles > | The Patriot-News - Harrisburg PA

Germany Approves Novartis H1N1 Vaccine

11/5/09 View all Related Articles > | The Wall Street Journal

Novartis receives regulatory approval for Celtura in Germany

11/5/09 | Theflyonthewall.com

Novartis Cell-Based H1N1 Vaccine Gets German OK

11/5/09 View all Related Articles > | SmartMoney

Wednesday, November 4, 2009

'Fast Money' Recap: Cisco's Bullish Report

11/4/09 | TheStreet.com

MIT Enterprise Forum of Cambridge Presents "Vaccines and Global Health: New Technologies Create Global Opportunities"

11/4/09 | Marketwire

You Don't Need Much to Start

11/4/09 | The Motley Fool

Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update

11/4/09 View all Related Articles > | Genetic Engineering News

Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update

11/4/09 | Business Wire

Novartis offers to acquire majority stake in Zhejiang Tianyuan

11/4/09 | Theflyonthewall.com

Novartis to expand its human vaccines presence in China through proposed acquisition of a majority stake in Zhejiang Tianyuan ..

11/4/09 View all Related Articles > | PR-inside - Austria

Tuesday, November 3, 2009

Novartis Adds 1MW Solar Array

11/3/09 | Sustainable Business.com

Novartis to Spend $1.25B on China R&D

11/3/09 View all Related Articles > | BusinessWeek

Antidepressants: promising candidates are Servier and Novartis's melatonin agonist and serotonin antagonist Valdoxan (agomelatine) ..

11/3/09 View all Related Articles > | PR-inside - Austria

Nice Quarter, Teva. What Will You Buy Next?

11/3/09 View all Related Articles > | The Motley Fool

This Stable Stock Could Still Surprise

11/3/09 | The Motley Fool

Vanda's Fanapt should reach pharmacy shelves next year, Washington Post says

11/3/09 | Theflyonthewall.com

Novartis to Invest in China

11/3/09 | The Wall Street Journal

SEC Filing: Foreign Issuer Report

11/3/09 | Thomson Financial

Novartis announces $1B investment to build R&D center in China

11/3/09 | Theflyonthewall.com

UPDATE 1-Novartis invests $1 bln in China R&D plant

11/3/09 | Interactive Investor - UK

Monday, November 2, 2009

Finally Convinced? Benlysta Works!

11/2/09 | The Motley Fool

Get Ready for the Fall?

11/2/09 | The Motley Fool

Novartis turns down Idenix's lead HCV candidate

11/2/09 | Script World Pharmaceutical News - UK

Winners and Losers of the House Health-Care Reform Bill

11/2/09 | The Motley Fool

Vanda Pharmaceuticals Reports Third Quarter 2009 Results

11/2/09 View all Related Articles > | StockWatch

Vanda Pharmaceuticals Reports Third Quarter 2009 Results

11/2/09 | PR Newswire

1 <Next>
Monday, November 9, 2009

Big Pharma and Biotech - Industry Outlook

11/9/09 | Zacks Investment Research

A Big Upgrade for Gilead Sciences

11/9/09 | The Motley Fool

Supreme Court to review business method patents, WSJ reports

11/9/09 | Theflyonthewall.com

Practicing Balance with P&G: China Watch

11/9/09 | TheStreet.com

Thursday, November 5, 2009

South Korean FDA raids Roche office over Tamiflu investigation, FT reports

11/5/09 | Theflyonthewall.com

Distribution of H1N1

11/5/09 | CNBC Video

Lower Q3 Loss for Human Genome - Analyst Blog

11/5/09 | Zacks Investment Research

Germany Approves Novartis H1N1 Vaccine

11/5/09 View all News Related Articles > | The Wall Street Journal

Novartis receives regulatory approval for Celtura in Germany

11/5/09 | Theflyonthewall.com

Novartis Cell-Based H1N1 Vaccine Gets German OK

11/5/09 View all News Related Articles > | SmartMoney

Wednesday, November 4, 2009

'Fast Money' Recap: Cisco's Bullish Report

11/4/09 | TheStreet.com

Novartis is making a multipronged push into China

11/4/09 View all News Related Articles > | DailyFinance

You Don't Need Much to Start

11/4/09 | The Motley Fool

Novartis offers to acquire majority stake in Zhejiang Tianyuan

11/4/09 | Theflyonthewall.com

Novartis to expand its human vaccines presence in China through proposed acquisition of a majority stake in Zhejiang Tianyuan

11/4/09 | Hugin Online - Netherlands

Tuesday, November 3, 2009

Novartis to Spend $1.25B on China R&D

11/3/09 View all News Related Articles > | BusinessWeek

Nice Quarter, Teva. What Will You Buy Next?

11/3/09 | The Motley Fool

This Stable Stock Could Still Surprise

11/3/09 | The Motley Fool

Vanda's Fanapt should reach pharmacy shelves next year, Washington Post says

11/3/09 | Theflyonthewall.com

Novartis to Invest in China

11/3/09 | The Wall Street Journal

SEC Filing: Foreign Issuer Report

11/3/09 | Thomson Financial

Novartis announces $1B investment to build R&D center in China

11/3/09 | Theflyonthewall.com

Monday, November 2, 2009

Finally Convinced? Benlysta Works!

11/2/09 | The Motley Fool

Get Ready for the Fall?

11/2/09 | The Motley Fool

Winners and Losers of the House Health-Care Reform Bill

11/2/09 | The Motley Fool

Friday, October 30, 2009

Shrugging Off the Side Effects

10/30/09 | The Motley Fool

Earnings? Yawn. Trial Data? Moving!

10/30/09 | The Motley Fool

It's Not as Frightening As It First Appears

10/30/09 View all News Related Articles > | The Motley Fool

Of One-Time Gains and Pipelines

10/30/09 | The Motley Fool

Should You Dump These Dividend Stocks?

10/30/09 | The Motley Fool

Idenix down; Novartis won't license drug candidate

10/30/09 | AP ONLINE

World's Scariest Stocks: Pfizer

10/30/09 | The Motley Fool

Idenix Pharma partnership for IDX184 still likely, says Wedbush

10/30/09 | Theflyonthewall.com

Novartis not licensing Idenix's hepatitis C drug

10/30/09 | AP ONLINE

SEC Filing: Foreign Issuer Report

10/30/09 View all News Related Articles > | Thomson Financial

Thursday, October 29, 2009

Novartis decides not to exercise option to license Idenix's IDX148

10/29/09 | Theflyonthewall.com

Eye on Insiders: Amgen

10/29/09 | The Motley Fool

The Winning Opportunity No One Talks About

10/29/09 | The Motley Fool

Novartis on track to deliver H1N1 vaccine for U.S.

10/29/09 | Theflyonthewall.com

Novartis International AG

10/29/09 | Hugin Online - Netherlands

1 <Next>
Monday, November 9, 2009

Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million

11/9/09 View all Trade Related Articles > | StockWatch

The first movers in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer ..

11/9/09 | PR-inside - Austria

Saturday, November 7, 2009

Novartis Receives Regulatory Approval In Germany For Celtura®, A Cell Culture-based Influenza A(H1N1) Pandemic Vaccine

11/7/09 View all Trade Related Articles > | PharmaInfo.net - Canada

Thursday, November 5, 2009

Novartis receives regulatory approval in Germany for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine

11/5/09 | PharmiWeb.com - UK

Novartis receives regulatory approval in Germany for Celtura, a cell culture-based Influenza A(H1N1) pandemic vaccine

11/5/09 | PharmaLive

Switzerland/China: Betting on brains

11/5/09 View all Trade Related Articles > | Economist Intelligence Unit

Novartis receives regulatory approval in Germany for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine

11/5/09 View all Trade Related Articles > | PR-inside - Austria

Wednesday, November 4, 2009

Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update

11/4/09 View all Trade Related Articles > | Genetic Engineering News

Novartis to expand its human vaccines presence in China through proposed acquisition of a majority stake in Zhejiang Tianyuan ..

11/4/09 | PR-inside - Austria

Tuesday, November 3, 2009

Novartis Adds 1MW Solar Array

11/3/09 | Sustainable Business.com

Antidepressants: promising candidates are Servier and Novartis's melatonin agonist and serotonin antagonist Valdoxan (agomelatine) ..

11/3/09 View all Trade Related Articles > | PR-inside - Austria

UPDATE 1-Novartis invests $1 bln in China R&D plant

11/3/09 | Interactive Investor - UK

Monday, November 2, 2009

Novartis turns down Idenix's lead HCV candidate

11/2/09 | Script World Pharmaceutical News - UK

Vanda Pharmaceuticals Reports Third Quarter 2009 Results

11/2/09 View all Trade Related Articles > | StockWatch

Friday, October 30, 2009

Novartis not licensing Idenix's hepatitis C drug

10/30/09 View all Trade Related Articles > | Bioscience Technology

Thursday, October 29, 2009

UPDATE 1-Idenix says Novartis not to license Hepatitis C drug

10/29/09 | Interactive Investor - UK

Novartis' Ilaris approved in EU for CAPS

10/29/09 | PharmaTimes - UK

Novartis on track to deliver Influenza A (H1N1) vaccine for the US

10/29/09 | PharmiWeb.com - UK

Wednesday, October 28, 2009

Cequent Says In-House IBD Candidate Will Likely Move to Clinic Before Novartis-Optioned Rx

10/28/09 | GenomeWeb

Novartis Champions Renewable Energy With New Vacaville Solar Array

10/28/09 View all Trade Related Articles > | StockWatch

10/28/09 - Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanaptâ?¢, an FDA-Approved Oral Therapy for Schizophrenia

10/28/09 | Pharmacy Choice

Novartis biological drug Ilaris® approved in EU to treat children and adults with CAPS, a rare debilitating auto-inflammatory disease ..

10/28/09 View all Trade Related Articles > | PR-inside - Austria

Tuesday, October 27, 2009

Female Sales Reps Get a Trial Date Against Novartis

10/27/09 | Corporate Counsel

Monday, October 26, 2009

Female Sales Reps Get a Trial Date Against Novartis

10/26/09 View all Trade Related Articles > | Law.com

10/26 - Orion Group Interim Report January-September 2009

10/26/09 View all Trade Related Articles > | Pharmacy Choice

Novartis Receives Approval in the European Union for Exforge HCT, a New 3-In-1 Treatment for High Blood Pressure

10/26/09 | Biocompare

Saturday, October 24, 2009

Novartis Profits Mild in 3rd Quarter

10/24/09 | Drug Discovery & Development

Friday, October 23, 2009

Novartis receives approval in the European Union for Exforge HCT®, a new 3-in-1 treatment for high blood pressure

10/23/09 View all Trade Related Articles > | PR-inside - Austria

Thursday, October 22, 2009

Novartis Corporation Female Sales Representatives Discrimination Suit to go to Trial

10/22/09 View all Trade Related Articles > | BioSpace

Novartis:Diovan Decline To Accelerate On Generic Cozaar Launch

10/22/09 | NASDAQ

Novartis AG (NYSE:NVS) – EBITDA margin in-line with our expectation in 3Q 09.

10/22/09 | IIR Group

Solid quarter for Novartis as firm waits for swine flu windfall

10/22/09 | PharmaTimes - UK

UPDATE 1-Vectura must wait for Novartis lung drug payment

10/22/09 View all Trade Related Articles > | Interactive Investor - UK

Novartis posts 1 percent growth in 3Q net profit

10/22/09 View all Trade Related Articles > | Bioscience Technology

Novartis profit down 8pct over nine months

10/22/09 | TradingRoom

Novartis delivers strong new product momentum and operational performance in first nine months of 2009

10/22/09 View all Trade Related Articles > | PR-inside - Austria

Wednesday, October 21, 2009

Human Genome Sciences gets $75M from Novartis

10/21/09 | Bioscience Technology

Novartis touts benefits of Tasigna over Glivec

10/21/09 View all Trade Related Articles > | PharmaTimes - UK

Novartis Drug Tasigna(R) Meets Primary Endpoint In Pivotal Trial Against Gleevec(R) As First-line Treatment In Chronic Myeloid Leukemia Patients

10/21/09 View all Trade Related Articles > | MediLexicon

Tuesday, October 20, 2009

FDA wants more data on Novartis' COPD drug indacaterol

10/20/09 | PharmaTimes - UK

1 <Next>
Thursday, November 5, 2009

Germany OK's Novartis swine flu vaccine from cells

11/5/09 | The Boston Globe - Boston MA

Germany OK's Novartis swine flu vaccine from cells

11/5/09 | The Patriot-News - Harrisburg PA

Thursday, October 29, 2009

Novartis Says On Track To Deliver US Vaccine Order

10/29/09 View all Regional Related Articles > | ABC - WCVB 5 - Boston MA

Novartis Says On Track To Deliver US Vaccine Order

10/29/09 View all Regional Related Articles > | ABC - KOCO 5 - Oklahoma City OK

Novartis: US To Get 30M H1N1 Vaccine Doses

10/29/09 View all Regional Related Articles > | ABC - WPBF 25 - West Palm Beach FL

Thursday, October 22, 2009

Novartis posts slight profit gain, to $2.1B

10/22/09 | Triangle Business Journal - Raleigh NC

Novartis says 3Q profit up 1 pct, raises outlook

10/22/09 View all Regional Related Articles > | The San Diego Union Tribune - San Diego CA

Wednesday, October 21, 2009

Novartis discrimination suit to go to trial

10/21/09 | Trenton Times - Trenton NJ

Tuesday, October 13, 2009

Novartis-Vanda deal benefits Titan Pharma

10/13/09 View all Regional Related Articles > | San Francisco Business Times - San Francisco CA

Friday, October 9, 2009

Locus, Novartis to collaborate

10/9/09 | Philadelphia Business Journal - Philadelphia PA

Paratek, Novartis strike licensing deal

10/9/09 View all Regional Related Articles > | The Boston Globe - Boston MA

Thursday, October 1, 2009

Drug Maker Novartis Unable To Fill Connecticut VNAs' Seasonal Flu Vaccine Order

10/1/09 View all Regional Related Articles > | The Hartford Courant - Hartford CT

Thursday, September 3, 2009

Novartis: 1-dose swine flu vaccine a possibility

9/3/09 View all Regional Related Articles > | Pittsburgh Tribune-Review - Pittsburgh PA

Sunday, August 23, 2009

The Motley Fool: High dividends and taking stock in Novartis

8/23/09 | The Seattle Times - Seattle WA

Monday, August 17, 2009

FDA approves Novartis MS drug

8/17/09 View all Regional Related Articles > | Puget Sound Business Journal - Seattle WA

Sunday, August 16, 2009

Strong dollar puts drag on Novartis - Sun, 16 Aug 2009 PST

8/16/09 | The Spokesman-Review - Spokane WA

Sunday, August 9, 2009

Novartis CEO calls attack on family grave mean

8/9/09 View all Regional Related Articles > | The Patriot-News - Harrisburg PA

Friday, August 7, 2009

Opexa to develop stem cell technology with Novartis

8/7/09 | Houston Business Journal - Houston TX

Wednesday, August 5, 2009

Novartis Starts Testing Its Swine Flu Vaccine

8/5/09 View all Regional Related Articles > | ABC - WCVB 5 - Boston MA

Threats heat up for Novartis

8/5/09 View all Regional Related Articles > | Boston Herald - Boston MA

Friday, July 17, 2009

Alnylam and Novartis extend RNAi partnership

7/17/09 | Boston Business Journal - Boston MA

Thursday, July 16, 2009

Novartis Net Falls 10% On Currency Swings

7/16/09 View all Regional Related Articles > | NBC - KSBW - TV 8 - Salinas CA

Wednesday, July 15, 2009

OneWorld, Novartis sign diarrhea R&D deal

7/15/09 View all Regional Related Articles > | San Francisco Business Times - San Francisco CA

Tuesday, July 14, 2009

U.S. orders $690M in swine-flu vaccine from Novartis, $71M from GSK

7/14/09 | Triangle Business Journal - Raleigh NC

Friday, June 19, 2009

Novartis drug Ilaris wins FDA approval

6/19/09 View all Regional Related Articles > | Triangle Business Journal - Raleigh NC

Friday, June 12, 2009

Novartis Produces First H1N1 Vaccine

6/12/09 View all Regional Related Articles > | NBC - WGAL 8 - Lancaster PA

Novartis Makes First Batch Of H1N1 Vaccine

6/12/09 View all Regional Related Articles > | ABC - KMBC-TV - Kansas City MO

Monday, June 1, 2009

Novartis osteoporosis treatment approved in US

6/1/09 View all Regional Related Articles > | The Patriot-News - Harrisburg PA

Wednesday, May 6, 2009

CombinatoRx strikes deal with Novartis

5/6/09 View all Regional Related Articles > | Boston Business Journal - Boston MA

Tuesday, May 5, 2009

Novartis leases at Sorrento South

5/5/09 | San Diego Daily Transcript - San Diego CA

Monday, May 4, 2009

Booker addresses students at Novartis mentoring event

5/4/09 | Trenton Times - Trenton NJ

Thursday, April 23, 2009

Novartis posts 14 percent drop in 1Q profit

4/23/09 View all Regional Related Articles > | The Kansas City Star - Kansas City MO

Monday, March 23, 2009

MDRNA announces deal with Novartis

3/23/09 View all Regional Related Articles > | Puget Sound Business Journal - Seattle WA

Thursday, March 19, 2009

Novartis team building event benefits Pi...

3/19/09 View all Regional Related Articles > | Trenton Times - Trenton NJ

Thursday, March 5, 2009

Proteon raises $38m, signs deal with Novartis

3/5/09 View all Regional Related Articles > | The Boston Globe - Boston MA

Thursday, February 12, 2009

Novartis, Portola ink potential $575M deal

2/12/09 View all Regional Related Articles > | East Bay Business Times - Pleasanton CA

Wednesday, January 28, 2009

Novartis posts 62 pct rise in 4Q net profit

1/28/09 View all Regional Related Articles > | The Boston Globe - Boston MA

Wednesday, January 21, 2009

Live Updates:

Ticker

Dynamic view of the market

NOVARTIS A G

NVS

Stock price

Extended Hours

NOVARTIS A G Real-Time Headlines

Monday, November 9, 2009

Sunday, November 8, 2009

Saturday, November 7, 2009

Thursday, November 5, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, November 2, 2009

Monday, November 9, 2009

Thursday, November 5, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, November 2, 2009

Friday, October 30, 2009

Thursday, October 29, 2009

Monday, November 9, 2009

Saturday, November 7, 2009

Thursday, November 5, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, November 2, 2009

Friday, October 30, 2009

Thursday, October 29, 2009

Wednesday, October 28, 2009

Tuesday, October 27, 2009

Monday, October 26, 2009

Saturday, October 24, 2009

Friday, October 23, 2009

Thursday, October 22, 2009